Healthpoint Biotherapeutics Signs Brazilian Distribution Agreement For OASIS® Extracellular Matrix Product Line
05:05 EDT 6 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
FORT WORTH, Texas, June 6, 2012 /PRNewswire/ -- Healthpoint Biotherapeutics today announced the company has entered into a distribution agreement with Efe Consultoria & Importacao Ltda to commercialize the OASIS® Extracellular Matrix product ...
Other Sources for this Article
More From BioPortfolio on "Healthpoint Biotherapeutics Signs Brazilian Distribution Agreement For OASIS® Extracellular Matrix Product Line"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
